INSIG1 and breast carcinoma: Increased expression of the INSIG1 gene was described in breast cancer cell lines after treatment with gemcitabine and 5–FU [55], while decreased expression was detected after treating a laryngeal cancer cell line with low doses of paclitaxel [56], and after anacardic acid treatment in breast cancer cell lines [57].